Since natural chemicals can act as multi-targeted agents in the fight against cancer, recently, highly interested in using them to reduce the adverse effects of cancer treatment, therefore, developing novel and efficient therapeutic methods for cancer is paramount. Studies have demonstrated that Ru exhibits widespread pharmacological properties, such as antioxidant, anti-inflammatory, antiangiogenic, pro-apoptotic, and anti-proliferative activities. These qualities can potentially contribute to the prevention and treatment of cancer. This research aims to develop nano-lipid carriers (NLC) that transport the Ru to OV (SK-OV-3), forcing them to undergo apoptosis and ultimately terminate the cancer cell’s life. First, the molecular structure of water, and other materials were constructed using Material Studio software. Then, the structure of the molecules was optimized through the Forcite module in the software. In sequence, to set the temperature of the system the MD simulations were run under the NVT ensemble with velocity scale as a thermostat and total simulation time equal to 100 ps as the initialization step. We applied the hydrophobic-hydrophobic interactions and micellization process method to encapsulate Ru into NLC. The computational studies showed that in the first 30 ps of the simulation, the system was unstable, but after that, the system reached a stable condition. Moreover, we observed that the density of the system rapidly decreased to a stable mean value equal. Also, the characterizations using DLS and TEM imaging showed that the synthesized NPs have a size lower than 100 nm. The hemolysis evaluation showed that the Ru-micelles are hemocompatible and induced lower than 10 % hemolysis in all tested group. The result shows that the synthesized NLC loading efficiency was 73.63 %, and the particle size was 76 ± 3 nm. The Ru release experiment demonstrated that the loaded sample (Ru-NLC) exhibited a steady release effect, with a total release amount of 84.62 ± 1.61 % of the loaded quantity over 48 h. The findings of in vitro results indicate that Ru-NLC substantially impacts the metabolism of SK-OV-3 cells, and ultimately increases the amount of apoptosis protein levels. Because of these alterations, the cell’s capacity for growth is diminished, and it ultimately dies due to intrinsic apoptosis. The results of the Western blotting experiment indicate that Ru-NLC increases the apoptosis in cancer cells. At long last, we have demonstrated that loading Ru into NLC increased the solubility and bioavailability and could increase the therapeutic efficacy.
Read full abstract